Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen: Are we measuring disease burden or disease biology?

Benjamin A. Gartrell, Matthew D. Galsky

Research output: Contribution to journal › Editorial › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical decision making in castration-resistant prostate cancer according to baseline prostate-specific antigen: Are we measuring disease burden or disease biology?'. Together they form a unique fingerprint.